Clinical Trial

COVID-19: Respiratory and Sleep Follow-up

Study acronym: Co-SURVIVORS
Unknown
View on ClinicalTrials.gov →
Summary
The current project is a prospective, multicentric cohort study aiming at a multidisciplinary assessment (pulmonary, cardiometabolic, sleep and mental health) of the consequences of infection by SARS-CoV-2, 3 months after the diagnosis in order to better characterize these complications. 400 patients with a positive diagnosis of SARS-CoV-2 will be included in the study 3 months after their diagnosis: They will be followed at 6 months, 1 year, 3 years, and 5 years, as function of their after-effects discovered at 3 months and their evolution.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT04406324
Lead Sponsor University Hospital, Grenoble
Conditions COVID-19
Enrollment 395 participants
Start Date 2020-06-06
Primary Completion 2022-03-07 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-26